Tonix Pharmaceuticals Holding is focused on the development of innovative prescription medicines for challenging disorders of the central nervous system, targeting conditions characterized by significant unmet medical need, inadequate existing treatments and high patient and physician dissatisfaction. The company’s core technology improves sleep quality for patients suffering with chronic pain syndromes, and Tonix is developing formulations that have been optimized for new therapeutic uses. For more information, visit the company’s Web site at www.tonixpharma.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: